{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T17:35:58Z","timestamp":1648748158193},"reference-count":11,"publisher":"Oxford University Press (OUP)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mod Rheumatol"],"published-print":{"date-parts":[[2012,11]]},"DOI":"10.1007\/s10165-012-0611-3","type":"journal-article","created":{"date-parts":[[2012,3,6]],"date-time":"2012-03-06T00:55:00Z","timestamp":1330995300000},"page":"837-843","source":"Crossref","is-referenced-by-count":1,"title":["An investigation of the correlation between blood concentration of mizoribine and its efficacy in treatment of rheumatoid arthritis based on indices of drug survival and improvement in DAS28-CRP"],"prefix":"10.1093","volume":"22","author":[{"given":"Hideo","family":"Ohtsubo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanae","family":"Ohkura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaki","family":"Akimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiya","family":"Arishima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobuhiko","family":"Sunahara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomomaro","family":"Izumihara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobutaka","family":"Eiraku","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tamami","family":"Yoshitama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takemasa","family":"Matsuda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2012,3,6]]},"reference":[{"key":"611_CR1","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1007\/s10165-008-0089-1","volume":"18","author":"M Nawata","year":"2008","unstructured":"Nawata M, Saito K, Nakayamada S, Tanaka Y. Discontinuation of infliximab in rheumatoid arthritis patients in clinical remission. Mod Rheumatol. 2008;18:460\u20134.","journal-title":"Mod Rheumatol"},{"key":"611_CR2","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/S0268-0033(98)00109-0","volume":"14","author":"H Ishikawa","year":"1999","unstructured":"Ishikawa H. The clinical usefulness of mizoribine for rheumatic diseases. BIO Clinica. 1999;14:376\u20139. (in Japanese).","journal-title":"BIO Clinica"},{"key":"611_CR3","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.2169\/internalmedicine.49.3810","volume":"49","author":"K Ichinose","year":"2010","unstructured":"Ichinose K, Ida H, Kawakami A, Tsukada T, Ueki Y, Eguchi K, et al. Efficacy and safety of mizoribine by one single dose administration for patients with rheumatoid arthritis. Intern Med. 2010;49:2211\u20138.","journal-title":"Intern Med"},{"key":"611_CR4","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1007\/s10165-010-0373-8","volume":"21","author":"K Nishimura","year":"2011","unstructured":"Nishimura K, Nishino J, Kouchi A, Nakamura N, Nakajima S, Yokoe I, et al. Efficacy and safety of single-dose mizoribine for patients with rheumatoid arthritis: results at 6\u00a0months after switching from a multiple-dose regimen without a change in total daily dose. Mod Rheumatol. 2011;21:158\u201363.","journal-title":"Mod Rheumatol"},{"key":"611_CR5","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1046\/j.1442-200X.2003.01749.x","volume":"45","author":"H Tanaka","year":"2003","unstructured":"Tanaka H, Suzuki K, Nakahata T, Sato T, Ito E. Mizoribine oral pulse therapy for a patient with severe lupus nephritis. Pediatr Int. 2003;45:488\u201390.","journal-title":"Pediatr Int"},{"key":"611_CR6","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1111\/j.1442-200X.2006.02178.x","volume":"48","author":"K Nozu","year":"2006","unstructured":"Nozu K, Iijima K, Kamioka I, Fujita T, Yoshioka K, Tanaka R, et al. High-dose mizoribine treatment for adolescents with systemic lupus erythematosus. Pediatr Int. 2006;48:152\u20137.","journal-title":"Pediatr Int"},{"key":"611_CR7","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1007\/s00467-005-2025-3","volume":"20","author":"Y Ohtomo","year":"2005","unstructured":"Ohtomo Y, Fujinaga S, Takada M, Murakami H, Akashi S, Shimizu T, et al. High-dose mizoribine therapy for childhood-onset frequently relapsing steroid-dependent nephrotic syndrome with cyclosporin nephrotoxicity. Pediatr Nephrol. 2005;20:1744\u20139.","journal-title":"Pediatr Nephrol"},{"key":"611_CR8","first-page":"3643","volume":"28","author":"K Sonda","year":"1996","unstructured":"Sonda K, Takahashi K, Tanabe K, Funchinoue S, Hayasaka Y, Kawaguchi H, et al. Clinical pharmacokinetic study of mizoribine in renal transplantation patients. Transplant Proc. 1996;28:3643\u20138.","journal-title":"Transplant Proc"},{"key":"611_CR9","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1006\/bbrc.2000.3104","volume":"274","author":"S Takahashi","year":"2000","unstructured":"Takahashi S, Wakui H, Gustafsson JA, Zilliacus J, Itoh H. Functional interaction of the immunosuppressant mizoribine with the 14-3-3 protein. Biochem Biophys Res Commun. 2000;274:87\u201392.","journal-title":"Biochem Biophys Res Commun"},{"key":"611_CR10","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1007\/s10165-007-0567-x","volume":"17","author":"T Kuroda","year":"2007","unstructured":"Kuroda T, Hirose S, Tanabe N, Sato H, Nakatsue T, Ajiro J, et al. Mizoribine therapy for patients with lupus nephritis: the association between peak mizoribine concentration and clinical efficacy. Mod Rheum. 2007;17:206\u201312.","journal-title":"Mod Rheum"},{"key":"611_CR11","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1007\/s10165-006-0487-1","volume":"16","author":"E Tanaka","year":"2006","unstructured":"Tanaka E, Inoue E, Kawaguchi Y, Tomatsu T, Yamanaka H, Hara M, et al. Acceptability and usefulness of mizoribine in the management of rheumatoid arthritis in methotrexate-refractory patients and elderly patients, based on analysis of data from a large-scale observational cohort study. Mod Rheumatol. 2006;16:214\u20139.","journal-title":"Mod Rheumatol"}],"container-title":["Modern Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.springerlink.com\/index\/pdf\/10.1007\/s10165-012-0611-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,9]],"date-time":"2022-03-09T16:27:58Z","timestamp":1646843278000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10165-012-0611-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3,6]]},"references-count":11,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2012,11]]}},"alternative-id":["611"],"URL":"https:\/\/doi.org\/10.1007\/s10165-012-0611-3","relation":{},"ISSN":["1439-7595","1439-7609"],"issn-type":[{"value":"1439-7595","type":"print"},{"value":"1439-7609","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,3,6]]}}}